These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8159737)

  • 1. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
    Hensley K; Carney JM; Mattson MP; Aksenova M; Harris M; Wu JF; Floyd RA; Butterfield DA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3270-4. PubMed ID: 8159737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
    Butterfield DA; Martin L; Carney JM; Hensley K
    Life Sci; 1996; 58(3):217-28. PubMed ID: 9499162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
    Yatin SM; Yatin M; Varadarajan S; Ain KB; Butterfield DA
    J Neurosci Res; 2001 Mar; 63(5):395-401. PubMed ID: 11223914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
    Yatin SM; Aksenov M; Butterfield DA
    Neurochem Res; 1999 Mar; 24(3):427-35. PubMed ID: 10215518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.
    Varadarajan S; Yatin S; Kanski J; Jahanshahi F; Butterfield DA
    Brain Res Bull; 1999 Sep; 50(2):133-41. PubMed ID: 10535332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for beta-amyloid aggregation and neurotoxicity based on the free radical generating capacity of the peptide: implications of "molecular shrapnel" for Alzheimer's disease.
    Hensley K; Butterfield DA; Mattson M; Aksenova M; Harris M; Wu JF; Floyd R; Carney J
    Proc West Pharmacol Soc; 1995; 38():113-20. PubMed ID: 7480002
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
    Lockhart BP; Benicourt C; Junien JL; Privat A
    J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity.
    Kanski J; Varadarajan S; Aksenova M; Butterfield DA
    Biochim Biophys Acta; 2002 Mar; 1586(2):190-8. PubMed ID: 11959460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
    Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Hara H; Ohashi R; Takegoshi K; Fukuda H; Nagao M; Shimizu T; Shirasawa T
    Mini Rev Med Chem; 2007 Oct; 7(10):1001-8. PubMed ID: 17979802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.
    Tickler AK; Smith DG; Ciccotosto GD; Tew DJ; Curtain CC; Carrington D; Masters CL; Bush AI; Cherny RA; Cappai R; Wade JD; Barnham KJ
    J Biol Chem; 2005 Apr; 280(14):13355-63. PubMed ID: 15668252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase.
    Aksenov MYu ; Aksenova MV; Harris ME; Hensley K; Butterfield DA; Carney JM
    J Neurochem; 1995 Oct; 65(4):1899-902. PubMed ID: 7561891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
    Yatin SM; Varadarajan S; Link CD; Butterfield DA
    Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.
    Harris ME; Hensley K; Butterfield DA; Leedle RA; Carney JM
    Exp Neurol; 1995 Feb; 131(2):193-202. PubMed ID: 7895820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.
    Harris ME; Carney JM; Cole PS; Hensley K; Howard BJ; Martin L; Bummer P; Wang Y; Pedigo NW; Butterfield DA
    Neuroreport; 1995 Oct; 6(14):1875-9. PubMed ID: 8547588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
    Yatin SM; Aksenova M; Aksenov M; Markesbery WR; Aulick T; Butterfield DA
    J Mol Neurosci; 1998 Dec; 11(3):183-97. PubMed ID: 10344789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.
    Butterfield DA; Hensley K; Harris M; Mattson M; Carney J
    Biochem Biophys Res Commun; 1994 Apr; 200(2):710-5. PubMed ID: 8179604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
    Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
    J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation.
    Aksenov MY; Aksenova MV; Butterfield DA; Hensley K; Vigo-Pelfrey C; Carney JM
    J Neurochem; 1996 May; 66(5):2050-6. PubMed ID: 8780035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.
    Pike CJ; Walencewicz-Wasserman AJ; Kosmoski J; Cribbs DH; Glabe CG; Cotman CW
    J Neurochem; 1995 Jan; 64(1):253-65. PubMed ID: 7798921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.